Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes
Authors:
Open Access
- 22 June 2010
- journal article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 119 (7) , 273-282
Abstract
Hypoxic injury to cardiomyocytes is a stress that causes cardiac pathology through cardiac-restricted gene expression. SRF (serum-response factor) and myocardin are important for cardiomyocyte growth and differentiation in response to myocardial injuries. Previous studies have indicated that AngII (angiotensin II) stimulates both myocardin expression and cardiomyocyte hypertrophy. In the present study, we evaluated the expression of myocardin and AngII after hypoxia in regulating gene transcription in neonatal cardiomyocytes. Cultured rat neonatal cardiomyocytes were subjected to hypoxia, and the expression of myocardin and AngII were evaluated. Different signal transduction pathway inhibitors were used to identify the pathway(s) responsible for myocardin expression. An EMSA (electrophoretic mobility-shift assay) was used to identify myocardin/SRF binding, and a luciferase assay was used to identify transcriptional activity of myocardin/SRF in neonatal cardiomyocytes. Both myocardin and AngII expression increased after hypoxia, with AngII appearing at an earlier time point than myocardin. Myocardin expression was stimulated by AngII and ERK (extracellular-signal-regulated kinase) phosphorylation, but was suppressed by an ARB (AngII type 1 receptor blocker), an ERK pathway inhibitor and myocardin siRNA (small interfering RNA). AngII increased both myocardin expression and transcription in neonatal cardiomyocytes. Binding of myocardin/SRF was identified using an EMSA, and a luciferase assay indicated the transcription of myocardin/SRF in neonatal cardiomyocytes. Increased BNP (B-type natriuretic peptide), MHC (myosin heavy chain) and [3H]proline incorporation into cardiomyocytes was identified after hypoxia with the presence of myocardin in hypertrophic cardiomyocytes. In conclusion, hypoxia in cardiomyocytes increased myocardin expression, which is mediated by the induction of AngII and the ERK pathway, to cause cardiomyocyte hypertrophy. Myocardial hypertrophy was identified as an increase in transcriptional activities, elevated hypertrophic and cardiomyocyte phenotype markers, and morphological hypertrophic changes in cardiomyocytes.Keywords
This publication has 34 references indexed in Scilit:
- Resynchronization of Separated Rat Cardiomyocyte Fields With Genetically Modified Human Ventricular Scar FibroblastsCirculation, 2007
- Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin geneThe FASEB Journal, 2007
- Angiotensin II Receptor Blocker Reduces Oxidative Stress and Attenuates Hypoxia-Induced Left Ventricular Remodeling in Apolipoprotein E-Knockout MiceHypertension Research, 2007
- The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesisGenes & Development, 2006
- Partnering Up for Cardiac HypertrophyCirculation Research, 2006
- Glycogen Synthase Kinase 3β Inhibits Myocardin-Dependent Transcription and Hypertrophy Induction Through Site-Specific PhosphorylationCirculation Research, 2005
- Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardinCardiovascular Research, 2005
- Myocardin and Prx1 Contribute to Angiotensin II-Induced Expression of Smooth Muscle α-ActinCirculation Research, 2004
- Regulation of hypoxia-inducible factor-1α by cyclical mechanical stretch in rat vascular smooth muscle cellsClinical Science, 2003
- Regulation of Ribosomal DNA Transcription during Contraction-induced Hypertrophy of Neonatal CardiomyocytesJournal of Biological Chemistry, 1996